Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC supplements settlement

This article was originally published in The Tan Sheet

Executive Summary

Gero Vita International and six related defendants are required to pay monetary judgments of $605,000 after settling Federal Trade Commission charges related to deceptive marketing practices, FTC reports June 8. The defendants, including dietary supplement direct marketer Almon Glenn Braswell, claimed their products could cure or treat illnesses and conditions such as diabetes, Alzheimer's disease and obesity, the agency says. FTC originally filed the complaint in May 2003 (1"The Tan Sheet" June 2, 2003, p. 13). The defendants are barred from making future misleading product claims in addition to the fines. The $605,000 settlement resulted from the suspension of a $30 mil. judgment based on the defendants' inability to pay. However, the defendants will have to pay the total $30 mil. if they misrepresented their financial condition or Braswell does business with any other defendant, FTC says...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098304

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel